I help early-stage biotech and life science companies translate their science into clinical credibility,
meaningful key opinion leader (KOL) relationships, and investor-ready narratives — without the overhead of a full-time hire.
The problem I solve
Pre-seed and seed-stage biotechs are building novel science — but rarely have
someone who can speak it fluently to clinicians and key opinion leaders, prepare it for investor diligence,
and flag the regulatory considerations that protect the company long-term.
The companies that reach their next milestone with clinical momentum are the ones that lay this groundwork early.
That gap is where I operate.
You might need this if
→
Your science is compelling but your investor pitch isn't landing with scientific or clinical stakeholders
→
You know you need relationships with leading clinicians and clinical experts but don't know who to approach, how to structure the conversation, or what to ask
→
Your team is making scientific claims in pitch decks or on your website that haven't been validated against regulatory expectations
→
You're preparing for your next raise and need peer-reviewed evidence, congress presence, or clinical validation to strengthen your scientific narrative
→
You haven't mapped the clinical landscape — who the key clinicians are, what they need, and how your platform fits into their practice — critical groundwork that's easy to overlook at the early stages
→
You're a technical founder wearing too many hats — and even with AI tools, scientific outreach, clinical engagement, and evidence strategy are falling through the cracks
What I deliver
Scientific Narrative & Evidence Communication
Translate complex platform science into clinical language for investors, KOLs, and HCPs — including pitch deck audits and scientific white papers.
Medical Writing & Publication Support
Support manuscript preparation, abstract submissions, and publication planning to help early-stage companies build their evidence base and establish scientific credibility.
KOL Identification & Mapping
Identify and vet key opinion leaders for your therapeutic or diagnostic area. Build a prioritized engagement list with scientific rationale and recommended outreach approach.
Peer-to-Peer Scientific Exchange
Serve as the scientific face of your company in meetings with KOLs, clinical investigators, and HCPs — gathering insights, building relationships, and supporting trial or adoption goals.
Regulatory Intelligence & Considerations
Provide early regulatory intelligence to help founders understand applicable pathways, evidence requirements, and scientific claim considerations — building regulatory awareness before it becomes a bottleneck.
Medical Affairs & Clinical Advisory
Identify evidence gaps, support clinical positioning, study design considerations, and congress intelligence — laying the scientific groundwork before a full medical affairs hire makes sense.
Conference & meeting representation
Attend conferences and meetings on your company's behalf — conducting competitive intelligence, engaging KOLs and clinical investigators, sharing and communicating data, and representing your platform to the broader scientific community. Findings are synthesized into actionable post-congress briefings for your leadership team.
How we work together
I
Discovery Call
A conversation to understand your science, current stage, and where scientific or clinical strategy support is needed.
II
Scope & Proposal
A defined scope, timeline, and fee structure — project-based, retainer, or per-engagement — so you know exactly what to expect before committing.
III
Embedded Work
I immerse myself in your platform, data, and the surrounding literature, then execute — drafting, KOL mapping and outreach, or representing you at a conference or meeting.
IV
Deliver & Advise
You receive the deliverable, a debrief on findings and field insights, strategic implications, and recommended next steps — with ongoing check-ins for retainer engagements.
Proof points
01
Led an IRB-approved translational clinical study within a GCP-regulated trial environment validating a novel liquid biopsy platform for CTC capture in advanced cancer patients — responsibilities spanned IRB support, sample logistics, protocol adherence, data reporting, and coordination with a clinical collaborator.
02
5 peer-reviewed publications in oncology and thrombosis, with research experience spanning cellular diagnostics and therapeutics, platelet–cancer interactions, and liquid biopsy platforms; 8+ national conference presentations; contributed to successful grant submissions through technical writing and preliminary data generation.
03
Board Certified Medical Affairs Specialist (BCMAS); M.Eng. in Regulatory Biomedical Engineering; NIH IPPCR-certified in clinical research principles and practice.
04
Invited peer reviewer for 6 oncology-hematology journals; Adjunct Professor of Biomedical Engineering with demonstrated scientific communication across diverse audiences.
Domain expertise
Biomedical Engineering
Life Sciences
Oncology
Liquid Biopsy & Diagnostics
Circulating Tumor Cells (CTC)
ctDNA / MRD
Platelet–Cancer Interactions
Hematology
Tumor Microenvironment & Metastasis
Cellular Therapeutics
Credentials
PhD · Biomedical Engineering — Cellular Diagnostics & Therapeutics (GWU)
Board Certified Medical Affairs Specialist (BCMAS)
M.Eng · Regulatory Biomedical Engineering
NIH Introduction to Principles & Practice of Clinical Research (IPPCR)
Member · Medical Science Liaison Society (MSLS)
Member · Women in Bio
Ideal engagements
Pre-seed & seed life science startups
Series A/B raising scientific credibility
Companies preparing for first clinical study or KOL engagement
Diagnostic companies & liquid biopsy platforms
CTC / ctDNA platforms
AI-powered diagnostic platforms
Multi-cancer early detection (MCED)
Cell-Based Therapeutics
Academic spinouts entering commercial translation
International founders building US presence & strategy